Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew P Leese

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Beilstein Journal of Organic Chemistry|October 25, 2017
Accessing simply-substituted 4-hydroxytetrahydroisoquinolines via Pomeranz-Fritsch-Bobbitt reaction with non-activated and moderately-activated systemsMarco Mottinelli, Mathew P Leese, Barry V L Potter
International Journal of Cancer|May 10, 2005
Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamatesBindumalini Raobaikady, Michael J Reed, Mathew P Leese, et al.
Chemmedchem|November 5, 2020
N-Phenyl-1,2,3,4-tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β-Hydroxysteroid Dehydrogenase 1 InhibitorsMarco Mottinelli, Maša Sinreih, Tea L Rižner, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agentsMathew P Leese, Simon P Newman, Atul Purohit, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamatesMathew P Leese, Bertrand Leblond, Simon P Newman, et al.
Chemmedchem|May 14, 2014
Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptorsWolfgang Dohle, Mathew P Leese, Fabrice L Jourdan, et al.
Journal of Medicinal Chemistry|May 25, 2011
Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agentsFabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamateBindumalini Raobaikady, Atul Purohit, Surinder K Chander, et al.
Biochemistry|March 20, 2010
Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitorsGyles E Cozier, Mathew P Leese, Matthew D Lloyd, et al.
Anticancer Research|October 23, 2009
STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cellsPaul A Foster, Yaik T Ho, Simon P Newman, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Beilstein Journal of Organic Chemistry|October 25, 2017
Accessing simply-substituted 4-hydroxytetrahydroisoquinolines via Pomeranz-Fritsch-Bobbitt reaction with non-activated and moderately-activated systemsMarco Mottinelli, Mathew P Leese, Barry V L Potter
International Journal of Cancer|May 10, 2005
Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamatesBindumalini Raobaikady, Michael J Reed, Mathew P Leese, et al.
Chemmedchem|November 5, 2020
N-Phenyl-1,2,3,4-tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β-Hydroxysteroid Dehydrogenase 1 InhibitorsMarco Mottinelli, Maša Sinreih, Tea L Rižner, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agentsMathew P Leese, Simon P Newman, Atul Purohit, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamatesMathew P Leese, Bertrand Leblond, Simon P Newman, et al.
Chemmedchem|May 14, 2014
Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptorsWolfgang Dohle, Mathew P Leese, Fabrice L Jourdan, et al.
Journal of Medicinal Chemistry|May 25, 2011
Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agentsFabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamateBindumalini Raobaikady, Atul Purohit, Surinder K Chander, et al.
Biochemistry|March 20, 2010
Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitorsGyles E Cozier, Mathew P Leese, Matthew D Lloyd, et al.
Anticancer Research|October 23, 2009
STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cellsPaul A Foster, Yaik T Ho, Simon P Newman, et al.
Pageof 4